Moreover, combined examination of NMB and CCL2 showed the discrimination of PNI with the AUC value of 0.914 (95% CI 0.828-1.000) in cervical cancer as compared to that of NMB or CCL2 alone, which may be clinical effective for the preoperative evaluation of PNI. This evidence concerns the gene CCL2 and cervical cancer.